AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $297,000 | +22.7% | 31,582 | -0.1% | 0.21% | +12.2% |
Q2 2020 | $242,000 | +23.5% | 31,607 | -0.5% | 0.19% | -3.6% |
Q1 2020 | $196,000 | -45.9% | 31,781 | +6.7% | 0.20% | -21.6% |
Q4 2019 | $362,000 | -6.5% | 29,780 | -11.2% | 0.25% | -13.8% |
Q3 2019 | $387,000 | +15.2% | 33,524 | -0.3% | 0.29% | +10.3% |
Q2 2019 | $336,000 | -22.4% | 33,619 | -0.0% | 0.26% | -25.3% |
Q1 2019 | $433,000 | -16.2% | 33,627 | -1.3% | 0.35% | -26.4% |
Q4 2018 | $517,000 | -24.4% | 34,062 | -0.5% | 0.48% | 0.0% |
Q3 2018 | $684,000 | +2.4% | 34,217 | -0.1% | 0.48% | +0.8% |
Q2 2018 | $668,000 | -3.6% | 34,259 | -0.4% | 0.47% | -6.3% |
Q1 2018 | $693,000 | +53.7% | 34,401 | +1.0% | 0.51% | +56.7% |
Q4 2017 | $451,000 | -36.3% | 34,071 | -11.2% | 0.32% | -35.0% |
Q3 2017 | $708,000 | +0.3% | 38,358 | +0.0% | 0.50% | -2.7% |
Q2 2017 | $706,000 | -20.9% | 38,354 | -3.0% | 0.51% | -23.4% |
Q1 2017 | $892,000 | -37.3% | 39,546 | -3.3% | 0.67% | -35.8% |
Q4 2016 | $1,423,000 | +36.8% | 40,901 | -3.6% | 1.04% | +30.0% |
Q3 2016 | $1,040,000 | -4.8% | 42,416 | -7.1% | 0.80% | -2.3% |
Q2 2016 | $1,092,000 | -15.3% | 45,635 | -17.2% | 0.82% | -3.1% |
Q1 2016 | $1,289,000 | -53.3% | 55,097 | -39.7% | 0.84% | -25.8% |
Q4 2015 | $2,759,000 | -36.0% | 91,400 | -15.7% | 1.14% | -28.1% |
Q3 2015 | $4,308,000 | -59.9% | 108,423 | -30.3% | 1.58% | -36.0% |
Q2 2015 | $10,738,000 | -20.2% | 155,494 | -36.8% | 2.47% | -0.8% |
Q1 2015 | $13,457,000 | +20.3% | 246,186 | -6.2% | 2.49% | +22.1% |
Q4 2014 | $11,185,000 | +27.2% | 262,430 | -4.7% | 2.04% | +28.3% |
Q3 2014 | $8,790,000 | +43.1% | 275,472 | -7.1% | 1.59% | +62.4% |
Q2 2014 | $6,143,000 | -4.5% | 296,458 | -10.9% | 0.98% | +4.8% |
Q1 2014 | $6,435,000 | -25.5% | 332,576 | -6.6% | 0.93% | -22.3% |
Q4 2013 | $8,642,000 | +16.9% | 355,931 | +3.4% | 1.20% | +3.6% |
Q3 2013 | $7,390,000 | -1.3% | 344,116 | +2.3% | 1.16% | -12.7% |
Q2 2013 | $7,487,000 | – | 336,504 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |